Versican Proteolysis Predicts Immune Effector Infiltration And Post-Transplant Survival In Myeloma
B. Dhakal, A. Pagenkopf, M. U. Mushtaq, A. M. Cunningham, E. Flietner, Z. Morrow, A. Papadas, C. Hope, C. Leith, P. Hematti, P. Hari, N. S. Callander, F. Asimakopoulos
This study shows that VCAN proteolysis predicts CD8+ T cell infiltration and poor survival after myeloma transplantation, suggesting it as a biomarker for relapse risk.
bioRxiv · Sep 12, 2018Immunology